Business Standard

Thursday, January 30, 2025 | 07:13 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Gilead seeks US FDA approval for experimental coronavirus drug remdesivir

The antiviral drug has been at the forefront of the battle against the pandemic after the FDA granted it emergency use authorization (EUA) in May

Coronavirus, vaccine, covid, drugs, Sepsivac, clinical trials
Premium

Remdesivir has already been approved by multiple regulatory authorities around the world, including in the European Union, Australia and Japan.

Reuters
Gilead Sciences Inc has filed an application with the US Food and Drug Administration seeking full approval for remdesivir, its experimental Covid-19 drug currently used under emergency authorization, the drugmaker said on Monday.

The antiviral drug, which helped shorten the hospital recovery time in a US trial, has been at the forefront of the battle against the pandemic after the FDA granted it emergency use authorization (EUA) in May.

The authorization cleared the way for broader use of the drug in more hospitals around the United States, which has recorded over 162,600 Covid-19 deaths and over 5 million infections. But

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in